A global team of influential researchers, clinicians, regulators, and citizen advocates suggest how we can start to build an evidence base for healthcare that is free of commercial influences We all want to base our healthcare decisions on trustworthy evidence. Yet the landmark 2009 Institute of Medicine report identified widespread financial conflicts of interest across medical research,…
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its shortage list.
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two…
Researchers raise concerns in a recent commentary. Since 1990, the prevalence of childhood overweight and obesity has nearly doubled worldwide, affecting every continent. Although the…
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its shortage list.
Men, Baby Boomers, and postgraduate degree-holders were among those most likely to say they wouldn’t choose medication over dieting.
Diabetes Therapy – Obesity is both a major risk factor for diabetes and a serious comorbidity of the condition. The twin epidemics of obesity and…
GENEVA – Cardiometabolic diseases, a group of non-communicable diseases (NCDs) including cardiovascular disease, stroke, diabetes, and non-alcoholic fatty
UnitedHealth Group and CVS Health have petitioned a judge to sideline FTC Chair Lina Khan from the agency’s lawsuit against the largest pharmacy PBMs
UnitedHealth Group and CVS Health have petitioned a judge to sideline FTC Chair Lina Khan from the agency’s lawsuit against the largest pharmacy PBMs
Nuvance Health, parent company of Norwalk and Danbury hospitals, reportedly says it is losing hundreds of millions of dollars.
